A Randomized Crossover Clinical Trial to Evaluate the Efficacy of Oral Transmucosal Fentanyl Citrate in the Treatment of Dyspnea on Exertion in Patients With Advanced Cancer.
Conclusion:It could not be demonstrated that the OTFC improved exertion dyspnea in patients with advanced cancer. A placebo effect was observed in all the patients.
PMID: 24259406 [PubMed - as supplied by publisher]
Source: The American Journal of Hospice and Palliative Care - Category: Palliative Care Authors: Pinna MA, Bruera E, Moralo MJ, Correas MA, Vargas RM Tags: Am J Hosp Palliat Care Source Type: research
More News: Actiq | Cancer | Cancer & Oncology | Clinical Trials | Fentanyl | Lung Cancer | Morphine | Oral Cancer | Palliative | Palliative Care